SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending as investors debate the impact of agentic AI competition against the company's strong fundamentals and established enterprise role. While the community remains polarized by recent volatility and technical support levels, many are focused on the upcoming product showcase as a potential catalyst to shift the narrative and challenge short interest.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is seeing a surge in bullish sentiment driven by reports that Iran is increasingly using the cryptocurrency to facilitate oil trade and bypass traditional financial hurdles, alongside active community discussion regarding institutional buying records and the potential passage of the Clarity Act. Investors are closely monitoring price action around the 73k resistance level, with many debating whether geopolitical factors and increased adoption will fuel a breakout or if historical market patterns signal a short-term correction.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending due to a major multi-year compute deal with Anthropic and an expanded capacity agreement with Meta, which have energized investor interest in the stock. While these partnerships highlight CoreWeave's role as a critical AI infrastructure provider, the community is actively debating the impact of a concurrent debt offering, weighing the massive growth potential against the implications of ongoing corporate dilution.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

Pepe is currently generating significant market conversation centered on speculative buzz regarding a potential ETF filing, which supporters argue highlights the meme coin's growing institutional legitimacy and cultural staying power. While some community members remain wary of volatility and broader sector instability, others are leveraging this institutional interest to fuel discussions about upcoming price rallies and long-term holding strategies.

Maulcoin

Maulcoin is capturing attention as a community-driven project that is rallying behind the development of its ticker and charting integration, with supporters emphasizing its focus on organic growth and transparent tokenomics. The community is actively using social platforms to boost visibility and volume, framing the project as a long-term alternative to the volatility of other meme coin sectors.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending as investors react to a recent analyst upgrade and the company's decision to walk away from a potential Warner Bros. Discovery acquisition, with the community closely tracking its momentum toward the key $100 resistance level. Bullish sentiment is fueled by expectations of strong organic growth, while traders remain highly focused on upcoming earnings and potential technical breakouts.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is facing a sharp sell-off as investors grapple with sector-wide pressure and growing concerns that AI-driven disruption from companies like Anthropic could commoditize traditional enterprise software. While the stock has hit fresh multi-year lows, the community remains deeply divided, with some calling for capitulation and others identifying the pullback as a generational buying opportunity tied to the company's long-term enterprise infrastructure role.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

Pudgy Penguins is trending as community members highlight its transition from a digital asset to a "phygital" powerhouse with significant retail presence in major stores and the launch of new utility products like a Visa-backed card. Investors are actively discussing the project's long-term growth potential and real-world revenue streams as they navigate volatility and accumulation opportunities.

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

Organon & Co.

Organon is seeing intense market interest and a sharp price surge driven by unconfirmed headlines regarding a potential $12 billion acquisition bid by Sun Pharma. While the community is actively debating the credibility of the reports and the impact of the company's significant debt load, the stock remains a focal point for M&A speculators and those tracking a potential breakout.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Menlo Park, CA.

Snowflake Inc

Snowflake is facing intense volatility as the market reacts to a strong earnings report and AI growth metrics with a sharp sell-off, highlighting concerns over high valuations and competitive pressure from emerging AI models. Investors are currently torn between the company's solid revenue growth and the broader sector-wide repricing of high-multiple SaaS stocks amid fears of AI-driven disruption.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Top Biotech Stocks To Follow Today - February 1st

Danaher, Vertex Pharmaceuticals, Moderna, Vaxcyte, argenex, VivoSim Labs, and ImmunityBio are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks...

Biotech Stocks To Keep An Eye On - January 31st

Biotech Stocks To Follow Today - January 30th

Danaher, VivoSim Labs, Moderna, Vaxcyte, and Dianthus Therapeutics are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of companies...

<ul class="summary-bullets"><li>NAMKind human-based toxicology services is designed to help drug developers identify liver and gastrointestinal liabilities earlier in the development process.&nbsp;</li><li>The company also said that it is continuing to scale capacity to support expanding global demand.</li><li>The company also anticipates accelerated adoption of human tissue models following the U.S. Food and Drug Administration announcement last year that sought to reduce animal testing requirements.</li></ul>Shares of VivoSim Labs, Inc. (VIVS) rose about 79% on Friday after the company announced expansion into Korea and China for its NAMKind toxicology services.VivoSims <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2026/01/29/3229075/0/en/VivoSim-Expands-Asia-Pacific-Access-to-NAMKind-Human-Based-Toxicology-Services-Through-New-Distributor-Agreement-in-Korea-and-China.html">said</a> on Friday that it has signed JCBio as an authorized distributor in Korea and Tekon Biotech as an authorized distributor in China for NAMKind.<h2 class="st-heading-2">Expansion Details</h2>VivoSim Labs provides new approach methodologies for preclinical safety and NAMKind human-based toxicology services is designed to help drug developers identify liver and gastrointestinal liabilities earlier in the development process, helping avoid downstream failures.It also helps prioritize the right assets at the onset for pharmaceutical and biotechnology organizations.VivoSim said the new distributors will allow it to expand the company’s commercial presence across the Asia-Pacific.The company also said that it is continuing to scale capacity to support expanding global demand as drug developers seek earlier readouts, clearer translation to clinical outcomes, and meaningful reductions in late-stage attrition.The company also anticipates accelerated adoption of human tissue models following the U.S. Food and Drug Administration announcement last year that sought to reduce animal testing requirements in favor of non-animal methods. &nbsp;<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around VIVS stock rose from ‘bearish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume increased from ‘normal’ to ‘extremely high’ levels.“Not a bad session at all for momentum traders,” a Stocktwits user said. “Price moved cleanly higher. Buyers stayed in control.”<stembedurl>https://www.stocktwits.com/topstockalerts/message/643480801</stembedurl>Another user said they see a further rally up to $4.50.<stembedurl>https://www.stocktwits.com/MoeMoe66/message/643463733</stembedurl><a href="https://stocktwits.com/symbol/VIVS">VIVS stock</a> has lost about 27% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/cort-shares-plummer-on-fda-drug-rejection-letter-reveal/cmySqTUR4SV">CORT Shares Plummet On FDA’s Drug Rejection Letter Reveal — Here’s What Retail Has To Say</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Why Is VIVS Stock Up 79% Today?

VivoSims said on Friday that it has signed JCBio as an authorized distributor in Korea and Tekon Biotech as an authorized distributor in China for its NAMKind human-based toxicology services.

Equity

VivoSims said on Friday that it has signed JCBio as an authorized distributor in Korea and Tekon Biotech as an authorized distributor in China for its NAMKind human-based toxicology services.


VivoSim Labs, Inc. is engaged in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded on January 30, 2012 and is headquartered in San Diego, CA.

Current Price	$1.45
Prev Close	$1.53
Open	$1.50
Dividend Yield	0.00%
50-Day Moving Average	$1.91
Beta	0.42
Avg. Volume	103,007.05
PE Ratio	3.29

52-Week High	$5.30
52-Week Low	$1.25
Market Capitalization	$3.99M
EPS (Annual)	-$1.70
Price to Book	0.90
Revenue Per Employee	$11,076.92

VIVS
VivoSim Labs, Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest VIVS News

VIVSVivoSim Labs, Inc.